[
Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 88, 5808–5813, 2003.10.1210/jc.2003-030254
]Search in Google Scholar
[
Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93, 1553–1562, 2008.10.1210/jc.2008-0139
]Search in Google Scholar
[
Fierabracci P, Pinchera A, Martinelli S, Scartabelli G, Salvetti G, Giannetti M, Pucci A, Galli G, Ricco I, Querci G, Rago T, Di Salvo C, Anselmino M, Vitti P, Santini F. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg 21, 54–60, 2011.10.1007/s11695-010-0297-6
]Search in Google Scholar
[
Gungunes A, Sahin M, Demirci T, Ucan B, Cakir E, Arslan MS, Unsal IO, Karbek B, Caliskan M, Ozbek M, Cakal E, Delibasi T. Cushing’s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 47, 895–900, 2014.10.1007/s12020-014-0260-8
]Search in Google Scholar
[
Jankovic D, Wolf P, Anderwald CH, Winhofer Y, Promintzer-Schifferl M, Hofer A, Langer F, Prager G, Ludvik B, Gessl A, Luger A, Krebs M. Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg 22, 62–69, 2012.10.1007/s11695-011-0545-4
]Search in Google Scholar
[
Knoops AJ, van der Graaf Y, Mali WP, Geerlings MI. Age-related changes in hypothalamic-pituitary-adrenal axis activity in patients with manifest arterial disease. Endocrine 37, 231–238, 2010.10.1007/s12020-009-9291-y
]Search in Google Scholar
[
Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet 386, 913–927, 2015.10.1016/S0140-6736(14)61375-1
]Search in Google Scholar
[
Lammert A, Nittka S, Otto M, Schneider-Lindner V, Kemmer A, Kramer BK, Birck R, Hammes HP, Benck U. Performance of the 1 mg dexamethasone suppression test in patients with severe obesity. Obesity 24, 850–855, 2016.10.1002/oby.21442
]Search in Google Scholar
[
Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet 367, 1605–1617, 2006.10.1016/S0140-6736(06)68699-6
]Search in Google Scholar
[
Nieman LK. Diagnostic tests for Cushing’s syndrome. Ann NY Acad Sci 970, 112–118, 2002.10.1111/j.1749-6632.2002.tb04417.x12381546
]Search in Google Scholar
[
Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The Diagnosis of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93, 1526–1540, 2008.10.1210/jc.2008-0125238628118334580
]Search in Google Scholar
[
Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27, 193–202, 2004.10.1291/hypres.27.19315080378
]Search in Google Scholar
[
Reimondo G, Pia A, Allasino B, Tassone F, Bovio S, Borretta G, Angeli A, Terzolo M. Screening of Cushing’s syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol 67, 225–229, 2007.10.1111/j.1365-2265.2007.02865.x17547690
]Search in Google Scholar
[
Tamada D, Otsuki M, Kashine S, Hirata A, Onodera T, Kitamura T, Shimomure I. Obstructive sleep apnea syndrome causes a pseudo-Cushing’s state in Japanese obese patients with type 2 diabetes mellitus. Endocr J 60, 1289–1294, 2013.10.1507/endocrj.EJ13-0255
]Search in Google Scholar
[
Tiryakioglu O, Ugurlu S, Yalin S, Yirmibescik S, Caglar E, Yetkin DO, Kadioglu P. Screening for Cushing’s syndrome in obese patients. Clinics (Sao Paulo) 65, 9–13, 2010.10.1590/S1807-59322010000100003281528820126340
]Search in Google Scholar
[
van Hulsteijn LT, Pasquali R, Casanueva F, Haluzik M, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol 182, 11–21, 2020.10.1530/EJE-19-066631652416
]Search in Google Scholar
[
Yavuz DG, Apaydin T, Gunhan HG, Uygur MM. Assessment of 1 mg Dexamethasone suppression test in patients with obesity before bariatric surgery. Obesity Surgery 30, 4981–4985, 2020.10.1007/s11695-020-04865-x32803707
]Search in Google Scholar
